Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 5
2007 2
2008 2
2009 2
2010 1
2011 3
2012 2
2013 4
2014 3
2015 1
2017 1
2020 1
2022 2
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults: Beyond current classification.
Çerçi P, Kendirlinan R, Büyüköztürk S, Gelincik A, Ünal D, Demir S, Erkekol FÖ, Karakaya G, Dursun AB, Çelikel S, Ediger D, Abadoglu O, Bavbek S. Çerçi P, et al. Among authors: erkekol fo. Allergol Immunopathol (Madr). 2023 Sep 1;51(5):84-92. doi: 10.15586/aei.v51i5.946. eCollection 2023. Allergol Immunopathol (Madr). 2023. PMID: 37695234
Meloxicam-associated anaphylactic reaction.
Bavbek S, Erkekol FO, Dursun B, Misirligil Z. Bavbek S, et al. Among authors: erkekol fo. J Investig Allergol Clin Immunol. 2006;16(5):317-20. J Investig Allergol Clin Immunol. 2006. PMID: 17039673 Free article.
Fixed drug eruption due to meloxicam.
Ozdemir SK, Erkekol FO, Aydin O, Celik GE, Misirligil Z. Ozdemir SK, et al. Among authors: erkekol fo. J Investig Allergol Clin Immunol. 2011;21(5):419-20. J Investig Allergol Clin Immunol. 2011. PMID: 21905514 Free article. No abstract available.
Elderly and aged asthma have different characteristics: results of a multicenter study.
Damadoğlu E, Aktaş ÖÖ, Gemicioğlu B, Yilmaz N, Bozkuş F, Ayhan V, Kalpaklioğlu AF, Erkekol FÖ, Havlucu Y, Erel F, Aydin Ö, Ekici A, Baççioğlu A, Bariş SA, Buhari GK, Ceyhan B, Göksel Ö, Köse M, Dursun AB, Yildiz F, Yorgancioğlu A, Işik SR, Ediger D, Oğuzülgen İK, Demir AU, Karakaya G, Kalyoncu AF. Damadoğlu E, et al. Among authors: erkekol fo. Turk J Med Sci. 2023 Nov 18;54(1):309-315. doi: 10.55730/1300-0144.5792. eCollection 2024. Turk J Med Sci. 2023. PMID: 38812643 Free PMC article.
Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experience.
Celik GE, Karakaya G, Erkekol FO, Dursun AB, Gelincik A, Aydin O, Damadoglu E, Yucel T, Yorulmaz I, Dursun E, Buyukatalay ZC, Sozener ZC, Buyukozturk S, Kalyoncu AF. Celik GE, et al. Among authors: erkekol fo. Allergy Asthma Proc. 2023 Mar 1;44(2):106-114. doi: 10.2500/aap.2023.44.220103. Allergy Asthma Proc. 2023. PMID: 36872443
Physicians' preference for controller medication in mild persistent asthma.
Bakirtas A, Kutlu A, Baccioglu A, Erkekol FO, Bavbek S, Kalayci O; Asthma Section Board Members of Turkish National Society of Allergy and Clinical Immunology. Bakirtas A, et al. Among authors: erkekol fo. Respir Med. 2017 Oct;131:236-240. doi: 10.1016/j.rmed.2017.08.029. Epub 2017 Sep 1. Respir Med. 2017. PMID: 28947037 Free article.
Validity and Reliability of the Assessment Tool for Asthma (ATA) Questionnaire: the ATA Study.
Gemicioğlu B, Mungan D, Bavbek S, Yıldız F, Polatlı M, Naycı S, Erkekol FÖ, Türker H, Günen H, Çamsarı G, Abadoğlu Ö, Çımrın A, Dursun AB, Göksel Ö, Özdemir SK, Börekci Ş, Aydın Ö, Ocaklı B, Gür A, Baygul A, Mısırlıgil Z. Gemicioğlu B, et al. Among authors: erkekol fo. Turk Thorac J. 2020 Mar 1;21(2):93-99. doi: 10.5152/TurkThoracJ.2019.180186. Print 2020 Mar. Turk Thorac J. 2020. PMID: 32202998 Free PMC article.
33 results